Metformin and Mannose Inhibit Human Hepatic Stellate Cell Activation and Proliferation: Implications for Anti-Fibrotic Therapies in Patients with MPI Deficiency and Chronic Liver Disease
ISEF · 2020 Biomedical and Health Sciences
Overview
Introduction: Children with mutations in mannose phosphate isomerase (MPI) develop early liver fibrosis that can progress to require liver transplantation. We have previously shown that MPI loss in hepatic stellate cells (HSCs) promotes HSC activation and mannose can decrease HSC activation and expression of PDGFR a potent cytokine that promotes HSC proliferation. Metformin can decrease HSC activation and proliferation and promote mannose uptake in dermal fibroblasts. Therefore, we hypothesized that mannose supplementation would decrease HSC proliferation and have synergistic anti-proliferative and anti-fibrotic effects when combined with metformin. Methods: LX2 and primary human HSCs were treated with increasing concentrations of mannose +/- metformin for 24-72 hours and HSC proliferation assessed by MTT assays. Metformin effects on HSC activation were assessed by qPCR. A stable model of MPI loss was created using CRISPR-Cas9 lentiviral infection to study impact of mannose and metformin in a more physiologically relevant in vitro model of MPI deficiency. Results: 1) Mannose supplementation (25mM) alone reduced HSC proliferation and metformin significantly decreased HSC proliferation, though synergistic effects were not yet observed. 2) Metformin decreased markers of HSC activation and MPI expression, the latter which may reflect feedback inhibition resulting from increased endogenous intracellular mannose. 3) Decreased MPI activity and HSC activation was seen in CRISPR MPI cells and will serve as a tool for additional studies. Conclusion: Mannose and metformin can dampen HSC activation and proliferation. Future work focuses on impact of mannose metabolism on receptor signaling important for HSC biology and interplay with metformin.
Competition history
- ISEF 2020
Resources
Related projects
ISEF · 2019
Metformin as a Novel Method for Polychlorinated Biphenyl Induced Non-alcoholic Fatty Liver Disease Remediation in Danio rerio as a Model for Human Livers
ISEF · 2018
Effectiveness of Neratinib in Inhibiting or Reversing Hepatic Stellate Cell Activation
ISEF · 2019
Purification of Glycerol-3-Phosphate Dehydrogenase and Testing Its Sensitivity to Metformin
ISEF · 2018
Metformin Inhibits Bacterial Glycerol Metabolism: Implications for Medicinal Effect
ISEF · 2026
Escaping the Matrix: Identifying ADAMTSL2 as the Trigger for Irreversible Liver Fibrosis Through Protein Modeling
ISEF · 2019
Hexokinase Domain Containing 1 (Hkdc1): A Metabolic Regulator of Nonalcoholic Fatty Liver Disease (NAFLD)
JSHS · 2022
Cure of Breast Cancer - Year 5: A Novel Approach to Treating Hormonal Breast Cancer Using Diabetes Medication Through Clinical Database and 3D ex vivo Model
ISEF · 2016
Reducing the Risk of Alzheimer's in Type II Diabetes Patients
Closest projects by meaning, across every fair and year in the corpus.
Browse more like this
Source: Regeneron International Science and Engineering Fair